1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)
    Meeting Abstract

    Jones, R. L.; Blay, J. Y.; Agulnik, M.; Chugh, R.; Mir, O.; Italiano, A.; Thomas, D.; Gupta, A.; Jahan, T.; Cote, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Correlative analyses of serum biomarkers and efficacy outcomes in the randomized phase II trial of lenvatinib (LEN), everolimus (EVE), or LEN+EVE in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Motzer, R. J.; Glen, H.; Michaelson, M. D.; Larkin, J.; Minoshima, Y.; Kanekiyo, M.; Dairiki, R.; Sachdev, P.; Dutcus, C. E.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
    Meeting Abstract

    George, S.; Heinrich, M.; Chi, P.; Razak, A.; von Mehren, M.; Gordon, M.; Ganjoo, K. N.; Somaiah, N.; Trent, J. C.; Rodon Ahnert, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Biological features and clinical outcomes in atezolizumab (atezo)-treated patients (pts) with metastatic urothelial cancer (mUC) of the upper vs lower urinary tract (UTUC vs LTUC)
    Meeting Abstract

    Galsky, M. D.; Banchereau, R.; Kadel, E. E. 3rd; Ramirez-Montagut, T.; Mariathasan, S.; Thåström, A.; Rosenberg, J.; Powles, T.; van der Heijden, M. S.; Necchi, A.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems
    Meeting Abstract

    Hornberger, J.; Graf, R. P.; Hulling, M.; Attard, G.; Allan, A.; Dittamore, R.; Scher, H. I.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naive prostate cancer (HSPC)
    Meeting Abstract

    Harrison, M. R.; Davis, P. G.; Khouri, M. G.; Gupta, R. T.; Armstrong, A. J.; McNamara, M. A.; Zhang, T.; Anand, M.; Onyenwoke, K.; Hood, H.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Aljumaily, R.; Wong, D. J.; Autio, K. A.; Wainberg, Z. A.; Javle, M.; Bendell, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Weight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Di Meglio, A.; El-Mouhebb, M.; Michiels, S.; Jones, L.; Martin, E.; Matias, M.; Palhares, A. E. L.; Joly, F.; Vanlemmens, L.; Everhard, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC)
    Meeting Abstract

    Di Meglio, A.; El-Mouhebb, M.; Michiels, S.; Carene, D.; Everhard, S.; Martin, A. L.; Cottu, P. H.; Lerebours, F.; Coutant, C.; Lesur, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)
    Meeting Abstract

    Diamond, J. R.; Standifer, N.; Ascierto, M. L.; Morehouse, C.; Ghadially, H.; Canales, J. R.; Rebelatto, M. C.; Naidoo, J.; Mazzarella, L.; Patel, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save